Aerpio Pharmaceuticals Email Format
Pharmaceutical ManufacturingOhio, United States2-10 Employees
Aerpio Pharmaceuticals is a small pharmaceutical company based in Cincinnati, Ohio. It pursues the development and advancement of therapeutic candidates through collaborations with other biotech firms. In 2021, Aerpio merged with Aadibio, with Aadibio identified as the surviving entity in the transaction. The firm has active partnerships around drug candidates such as GB004, developed in collaboration with Gossamer Bio for inflammatory bowel disease. Earlier development efforts included AKB-9778 aimed at treating primary open-angle glaucoma. The company operates with a compact team, positioning itself within the broader pharmaceutical and biotech landscape.